Answers are grounded in this paper and cite their sources.
LSM is a useful tool for identifying patients at risk for liver cirrhosis and is superior to other NITs. The cut-offs of <10.2 and < 15.2 kPa reliably diagnose non-advanced liver fibrosis and exclude cirrhosis in the majority of patients. However, LSM cannot completely replace liver biopsy in CHD patients.
No takes yet. Share an insight, caveat, or question.
Sandmann et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: